Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

J. P. JPMAM)* today announced the final January 2025 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on ...

Larry Fink, the CEO of BlackRock, manages the world’s largest asset management firm, which handles a massive USD 7.4 trillion ...

Highlights:,Tevogen Bio,(NASDAQ:TVGN),shared insights on AI-driven drug development at the J.P. Morgan Healthcare Conference.

US President Donald Trump on Thursday accused the leaders of Bank of America and JPMorgan Chase of denying banking services to conservatives. Speaking via video link at the World Economic Forum in ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition ...

Analysts at J.P. Morgan sought to assuage investors on Friday about Carvana Co. after the online used-car sales platform drew intense criticism from short-seller Hindenburg Research, saying that ...

The nation's second-largest bank issued guidance that net interest income will reach up to $15.7 billion by next year's ...

Our calculations are based on comprehensive, delayed quotes. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

JP Morgan CEO Jamie Dimon said businesses are "encouraged by expectations for a more pro-growth agenda" heading into 2025.